Navigation Links
MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008
Date:10/29/2008

VALENCIA, Calif., Oct. 29 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD) will release its 2008 third quarter financial results on Wednesday, November 5, 2008 at 8:00 a.m. EST.

Management of the Company will host a conference call to discuss the third quarter financial results, clinical progress and other Company developments at 9:00 a.m. EST on November 5, 2008. Presenting from the Company will be its Chairman and Chief Executive Officer, Alfred Mann; President and Chief Operating Officer, Hakan Edstrom; Corporate Vice President and Chief Financial Officer, Matthew Pfeffer and Corporate Vice President and Chief Scientific Officer, Peter Richardson.

To participate in the live call by telephone, please dial (888) 677-5721 or (210) 839-8507. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com.

A telephone replay of the call will be accessible for approximately fourteen days following completion of the call by dialing (866) 411-1707 or (202) 369-0654. A replay will also be available on MannKind's website for fourteen days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its pipeline includes AFRESA(TM), which has completed Phase 3 clinical trials, and MKC253, which is c
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility
2. MannKind to Present at the UBS Global Life Sciences Conference
3. MannKind Corporation Reports Second Quarter Financial Results
4. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
5. MannKind to Present at Upcoming Conferences
6. MannKind Corporation Reports First Quarter Financial Results
7. MannKind to Present at the Morgan Stanley Healthcare Conference
8. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
9. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
10. MannKind Corporation Response to Recent Market Events
11. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... quickly produce ultra-lightweight, bendable batteries and supercapacitors in ... a sheet of paper with ink made of ... conductive storage device, said Yi Cui, assistant professor ... needs a low-cost, high-performance energy storage device, such ...
... 7 Vivakor, Inc. (OTC Bulletin Board: VIVK) today announced ... Chen and Fritz Lin, M.D. , Dr. Francis Chen ... as Board member of Vivakor, having held senior management positions ... Dr. Chen earned his Ph.D. in immunology from Harvard University, ...
... , VIENNA, Austria, December 7 ... for the,chemical industry, announced today that it has appointed Mr ... forward, EUCODIS Bioscience,sole focus will be to provide high-performance enzymes ... and,on its proven technology of "in vivo recombination". , ...
Cached Biology Technology:Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 2Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 3EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2
(Date:4/16/2014)... Armand-Frappier has just received a research grant from the ... nearly US$600,000. The 5-year grant is to pursue cutting-edge ... and to explore their biomedical potential in the field ... , "Receiving a grant at this level ... president of research and academic affairs at INRS. "It ...
(Date:4/16/2014)... array of finger-like projections called microvilli covers ... intestines., Vanderbilt University researchers have now discovered how ... critical for absorbing nutrients and defending against pathogens. ... Cell , reveal a role for adhesion ... understanding of intestinal pathologies associated with inherited and ...
(Date:4/16/2014)... memories improves during childhood, associated with structural changes ... and parietal cortices. New research from UC Davis ... this crucial time. Eventually, that could give insights ... into and during adolescence and affect memory, such ... the middle of the brain, the hippocampus plays ...
Breaking Biology News(10 mins):High-level NIH grant goes to professor Nicolas Doucet of INRS 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 3How kids' brain structures grow as memory develops 2
... To arrange for an interview with a researcher, please contact ... of each tip. For more information on ORNL and its research ... If you have a general media-related question or comment, you can ... -- Battling bugs . . . The software-writing ...
... have discovered a novel mechanism in Salmonella that ... its production of proteins in a previously unheard of manner. ... of certain proteins to respond to inhospitable conditions. ... were intrigued to find evidence of a similar mechanism in ...
... 29, 2010): Today, the Association for Molecular Pathology (AMP) submitted ... by the National Institutes of Health (NIH) for its Genetic ... membership to formulate a comprehensive response to the RFI. ... laboratory setting, AMP is able to inform the NIH on ...
Cached Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 2Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 3Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 4Mechanism uncovered behind Salmonella virulence and drug susceptibility 2Mechanism uncovered behind Salmonella virulence and drug susceptibility 3Mechanism uncovered behind Salmonella virulence and drug susceptibility 4AMP responds to Genetic Test Registry request for information 2
... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ... assistance. ID clarifier: tissue-culture treated ... cm 2 D H 245 ...
BD BioCoat Collagen IV 150 mm Culture Dishes...
...
...
Biology Products: